Catheter Precision, Inc.
VTAK
$0.3849
$0.02547.07%
| Weiss Ratings | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.62 | |||
| Price History | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 15.59% | |||
| 30-Day Total Return | -4.89% | |||
| 60-Day Total Return | 8.94% | |||
| 90-Day Total Return | -24.23% | |||
| Year to Date Total Return | -14.30% | |||
| 1-Year Total Return | -90.93% | |||
| 2-Year Total Return | -97.80% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -95.42% | |||
| 52-Week Low % Change | 27.83% | |||
| Price | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.40 | |||
| 52-Week Low Price | $0.30 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Jul 01, 2024 | |||
| Valuation | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.08M | |||
| Enterprise Value | 3.71M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -12.13 | |||
| Earnings Per Share Growth | -95.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.98 | |||
| Price/Book (Q) | 0.10 | |||
| Enterprise Value/Revenue (TTM) | 9.31 | |||
| Price | $0.38 | |||
| Enterprise Value/EBITDA (TTM) | -0.43 | |||
| Enterprise Value/EBIT | -0.34 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.05M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 973 691 2000 | |||
| Address | 1670 Highway 160 West Fort Mill, SC 29708 | |||
| Website | www.catheterprecision.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,704.01% | |||
| Profit Margin | -2,928.32% | |||
| Management Effectiveness | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.62% | |||
| Return on Equity | -- | |||
| Income Statement | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 399.00K | |||
| Total Revenue (TTM) | 399.00K | |||
| Revenue Per Share | $0.20 | |||
| Gross Profit (TTM) | 361.00K | |||
| EBITDA (TTM) | -8.69M | |||
| EBIT (TTM) | -10.79M | |||
| Net Income (TTM) | -11.68M | |||
| Net Income Avl. to Common (TTM) | -11.68M | |||
| Total Revenue Growth (Q YOY) | -27.82% | |||
| Earnings Growth (Q YOY) | -113.80% | |||
| EPS Diluted (TTM) | -12.13 | |||
| EPS Diluted Growth (Q YOY) | 29.01% | |||
| Balance Sheet | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.27M | |||
| Cash Per Share (Q) | $0.62 | |||
| Total Current Assets (Q) | 1.71M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 12.83M | |||
| Current Ratio (Q) | 0.663 | |||
| Book Value Per Share (Q) | $3.71 | |||
| Total Assets (Q) | 26.75M | |||
| Total Current Liabilities (Q) | 2.59M | |||
| Total Debt (Q) | 1.90M | |||
| Total Liabilities (Q) | 13.92M | |||
| Total Common Equity (Q) | 12.83M | |||
| Cash Flow | VTAK - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -85.00K | |||
| Cash from Financing (TTM) | 4.07M | |||
| Net Change in Cash (TTM) | -4.31M | |||
| Levered Free Cash Flow (TTM) | -4.70M | |||
| Cash from Operations (TTM) | -8.30M | |||
